| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.86▲ | 0.86▲ | 0.86▲ | 0.86▼ | 0.89▼ |
| MA10 | 0.86▲ | 0.86▲ | 0.86▲ | 0.88▼ | 0.94▼ |
| MA20 | 0.86▲ | 0.86▲ | 0.88▼ | 0.89▼ | 0.95▼ |
| MA50 | 0.89▼ | 0.87▼ | 0.87▼ | 0.94▼ | 1.05▼ |
| MA100 | 0.87▼ | 0.90▼ | 0.92▼ | 0.95▼ | 1.09▼ |
| MA200 | 0.91▼ | 0.94▼ | 0.97▼ | 1.01▼ | 1.51▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | 0.001▲ | -0.001▼ | -0.001▼ | -0.004▼ |
| RSI | 52.149▲ | 51.215▲ | 50.102▲ | 42.049▼ | 44.218▼ |
| STOCH | 70.287 | 64.606 | 48.516 | 32.734 | 24.772 |
| WILL %R | 0.000▲ | -31.911 | -31.911 | -64.356 | -83.962▼ |
| CCI | 95.319 | 63.999 | 27.292 | -61.431 | -74.458 |
|
Thursday, May 14, 2026 10:14 PM
RenovoRx Inc (RNXT) achieves its highest quarterly revenue and doubles its commercial cancer centers, signaling strong growth potential despite ongoing investment challenges.
|
|
Thursday, May 14, 2026 01:24 PM
Q1 2026 Revenue of $563,000 Totals Over 50% of Full Year 2025 Total RevenueActive Commercial Cancer Center Customers Expand to 16 with Growing ...
|
|
Thursday, May 14, 2026 01:24 PM
Q1 2026 Revenue of $563,000 Totals Over 50% of Full Year 2025 Total RevenueActive Commercial Cancer Center Customers Expand to 16 with Growing ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/05/26 | 0.8501 | 0.8721 | 0.84 | 0.855 | 161,246 |
| 13/05/26 | 0.8802 | 0.8802 | 0.8472 | 0.8486 | 174,945 |
| 12/05/26 | 0.86 | 0.8858 | 0.8388 | 0.8728 | 125,235 |
| 11/05/26 | 0.87 | 0.91 | 0.83 | 0.85 | 223,818 |
| 08/05/26 | 0.9116 | 0.9116 | 0.8545 | 0.8636 | 311,843 |
| 07/05/26 | 0.90 | 0.9281 | 0.88 | 0.8801 | 205,429 |
| 06/05/26 | 0.9226 | 0.9525 | 0.8898 | 0.8899 | 285,874 |
| 05/05/26 | 0.9072 | 0.9367 | 0.8898 | 0.9283 | 268,140 |
| 04/05/26 | 0.9003 | 0.92 | 0.8814 | 0.8852 | 146,497 |
| 01/05/26 | 0.86 | 0.92 | 0.8546 | 0.8833 | 386,427 |
|
|
||||
|
|
||||
|
|